H&T Presspart to Showcase Respiratory Drug Delivery Devices at CPhi Worldwide

H&T Presspart will be exhibiting at this year’s CPhI Worldwide exhibition in Frankfurt.

Taking place from the 23 October to 26 October, H&T Presspart will be located on stand 42C52 in the Innopack hall.

Visitors to the stand will be able to see H&T Presspart’s full range of respiratory drug delivery components, devices, and services.

As well as metered-dose inhaler cans and MDI actuators, H&T Presspart will be showcasing the recently launched PowdAir Plus dry powder inhaler. This new dry-poweder inhaler (DPI) is a complete unit with no metal or separate parts. Neat and compact, its novel, all-plastic, four-component design minimises manufacturing assembly and production costs.

H&T Pressparts range of MDI cans and actuators

H&T Presspart will be showcasing market-ready connected inhaler the eMDI, which is designed to improve patients’ adherence to medication doses, encourage self-care, and help health professionals maintain real-time monitoring.

The device integrates with Cohero Health’s BreatheSmart, a respiratory disease management platform that enables tracking of both controller and rescue medications, as well as measures lung function with clinical accuracy. Data is then transferred wirelessly to a smart phone app, or directly into a patient’s medical records.
Also on the stand will be H&T Presspart’s range of dose counters and dose indicators including the Quantum End of Life Indication System.

Together with co-located events ICSE, InnoPack, P-MEC, and FDF, CPhI Worldwide hosts more than 42,000 visiting pharmaceutical industry professionals over three days. More than 2,500 exhibitors from 153 countries gather at the event to network and take advantage of 150 free industry seminars. Every sector of the pharmaceutical market is represented under one roof.

More About This Company

About the eMDI

H&T Presspart and Cohero Health are currently collaborating with pharmaceutical manufacturers who are leveraging the...